ASRS 2020 coverage: Carl Danzig, MD, presented results of phase 2 Stairway Trial during the virtual 2020 American Society of Retina Specialists (ASRS) annual meeting. Faricimab is a bispecific antibody that simultaneously inhibits angiopoietin-2 and vascular endothelial growth factor A.
Technology is off to a good start, but improvements still needed
ASRS 2020 coverage: An augmented-reality device provides AMD patients with enhanced reading ability and facial recognition.
ASRS 2020 coverage: Intravitreal liposome-encapsulated bromfenac is under study as a treatment for refractory DME. Results of a pilot study were detailed at the virtual 2020 American Society of Retina Specialists (ASRS) annual meeting.
ASRS 2020 coverage: The Audacious Goals Initiative of the National Eye Institute is focused on developing noninvasive imaging advances to help patients with vision loss.
Diagnostic and monitoring advances in glaucoma need fine-tuning
With an eye on innovation, money is driving research of new therapies and devices.
Industry develops creative approaches to help increase patient medication adherence
One company is providing urgent eye care to patients in a refugee camp settlement of Rohingya.
Panel discusses IOP monitoring, drug delivery, data collection
For many physicians, “moral injury” may be actual issue
High-level observations for how the latest developments can help glaucoma specialists solve problems to achieve the utmost in patient care
Besides traditional medications, here are some of the many novel approaches to treat patients with glaucoma
There are other mimickers of NTG that should be kept in mind
New products increase the chance of early diagnosis
New therapies on the horizon offer options for slowing progression
Novel technologies range from invasive to non-invasive approaches
The American Medical Association, American Hospital Association and American Nurses Association on Monday urged Americans to wear a mask and practice social distancing in an effort to stem the spread of the coronavirus.
In a new survey by medical software provider Kyruus, nearly three quarters had tried virtual care during the COVID-19 pandemic and more than 75 percent said they were very or completely satisfied with their experience.
The CDC has updated the COVID-19 symptom list to include congestion or runny nose, nausea or vomiting, and diarrhea.
A team of researchers at the University of Alberta believe a case of pink eye is now a reason to be tested for COVID-19.
The North American Neuro-Ophthalmology Society, in alliance with the Spencer S. Eccles Health Sciences Library at the University of Utah, is offering the Neuro-Ophthalmology Virtual Education Library.
.png "Optometry Times"){kind=logo}
